Federal Trade Commission v. Raladam Co.

Background

The Federal Trade Commission, a government agency that stops unfair business practices, charged the Raladam Company with using deceptive advertising to sell a weight-loss product called Marmola. The Commission first acted in 1929 and issued a cease-and-desist order, but earlier courts and this Court had rejected the Commission’s findings in that prior record. In 1935 the Commission held new hearings, gathered much more evidence, and found in detail that Raladam’s statements about Marmola were misleading, that Marmola competed with many other antifat remedies, and that Marmola sold widely at retail with annual gross sales of about $350,000 to $400,000.

Reasoning

The central question was whether the Commission’s new findings were supported by substantial evidence showing that the misleading advertising had the tendency to divert trade and injure competitors. The Court said the later record was different and contained adequate proof. It accepted the Commission’s detailed findings that Marmola competed in an active interstate market, that desiccated thyroid was an ingredient also used in other remedies, and that the misleading claims could divert customers. The Court explained that the FTC may prevent unfair methods early, and it may infer likely diversion of trade when misleading statements target goods in active competition. The Court rejected Raladam’s argument that the earlier decision barred the new proceedings.

Real world impact

The ruling lets the FTC enforce a cease-and-desist order based on market-level evidence and detailed findings, not just proof of losses by specific named competitors. Companies that advertise competing weight-loss remedies nationwide can be stopped when their ads are found deceptive and likely to divert sales. The decision restores the Commission’s order and sends the case back for enforcement consistent with the opinion.